You might want to find:

ico-shop Shop

Trump & Weed Reforms – A Game Changer in the Cannabis Market?

Saira Zulfiqar

Written by

Dr. Saira Zulfiqar, PharmD

Updated on

July 08, 2025

Over the years, there has been a massive transformation in the cannabis industry, which can be attributed to a changing social attitude and emerging policies. With states increasingly supporting the legalization and medicinal use of cannabis, the industry is set to expand hugely. As this growth continues, policies must be reformed, and the most awaited updates will involve the cannabis industry, as suggested by President Donald Trump.

The policies that Trump advocates, such as the rescheduling of marijuana and his support of state independence, will have significant implications for the industry in 2025. Removing marijuana as a Schedule I drug and placing it into a lower category would recognize the medical purposes of the drug and remove at least some of the federal regulations in place hindering research and development. Also, President Trump on weed focuses on dealer-level decisions when it comes to cannabis regulations, which might give states more freedom on the matter of how they want to legalize cannabis and regulate it.

Breaking Down Trump on Weed Policies

Marijuana Rescheduling

One primary aspect of the positions that President Trump on weed has regarding cannabis reform is his advocacy of the rescheduling of marijuana, which is currently categorized as a Schedule I controlled substance, to make it into a Schedule III drug. 

According to the Controlled Substances Act:

  • Schedule I substances are high-potential abused substances with no accepted medical use. These include marijuana, heroin, ecstasy (a derivative of methamphetamine) and LSDs.
  • In contrast, Schedule III substances are accepted to have medical use but less potential abuse. These include ketamine, steroids, and codeine etc.

This shift would recognize the medical application of marijuana and ease some federal regulatory policies, allowing the cannabis industry to expand. 

  • It would facilitate the acquisition of required resources to which businesses could have access so that they could research cannabis more liberally. 
  • However, it should be noted that rescheduling does not take place automatically. It goes a long way through the Drug Enforcement Administration (DEA) and other federal approvals. It could be a slow bureaucratic procedure, and nobody can really say how fast this might materialize.

A new classification of cannabis would introduce us to a much wider sphere of research possibilities, particularly its utilization in medical spheres. 

  • It would permit scientists to research cannabis more in-depth, which would result in possible breakthroughs in treatments of numerous conditions. 
  • With additional research available, the industry may be looking into a higher demand for medical-grade cannabis products, opening potential doors to the cannabis business world.

Advocacy of State Autonomy

The second pillar of cannabis reform proposed by President Trump on Weed is that he remains firm in supporting the state over federal control in the legalization of cannabis. Trump has stressed the need to give the states the privilege of regulating the use of cannabis without unnecessary federal intervention. So, basically,

  • This reform would permit every state to normalize all cannabis usage based on their values and requirements, and therefore, a more dynamic regulatory structure in terms of the cannabis industry could be witnessed.
  • The autonomy of states would enable local governments to adopt the regulation of cannabis to more effectively address the needs of their areas’ demographics and social situations. As an example, a state displaying a history of cannabis farming, such as California, might decide to pursue its liberal cannabis regulations. In contrast, others will be covert with the guarantee or simply postpone the legalization. 
  • A more competitive market may also be introduced by state autonomy, as the companies of the different states would exist under their own regulations and legal frameworks, which, in turn, could introduce innovations in the industry.

Nonetheless, this strategy is not without hitches. Politics or social pressures may require some states to slow down on comprehensive cannabis frameworks. This might result in an imbalance in the country’s market development, which may negatively impact the development of business and interstate trade in cannabis.

Possible Implications for the Marijuana Business

Greater Research Opportunities

Probably one of the most hyped prospective effects of marijuana rescheduling is that it will lead to more research. Having cannabis classified as a Schedule III drug would mean additional funding would be available to conduct scientific research on its medical value. At this point, the Schedule I status of cannabis hinders cannabis research and makes it very difficult to perform such a field of study properly since it limits the access of researchers to cannabis.

It is also possible that the growing availability of cannabis to researchers may lead to an upsurge in clinical trials to investigate the potential side effects and uses of cannabis in the treatment of various medical disorders. This involves fields like:

  • Pain management (chronic)
  • Mental disorders
  • Epilepsy
  • Cancer management

Researchers can also examine the effect of the compound on different groups of the population, such as children, the elderly, and individuals with numerous chronic diseases.

This move may be a game-changer for businesses. New medical uses of cannabis may give businesses a chance to create new products to serve the pharmaceutical and wellness industries. A new flood of access to research money and institutional backing might ignite a burst of creativity, driving the industry into the future.

Enhanced Access to Banking

Today, businesses related-to-cannabis have a problem regarding accessing banking services. Due to the illegal status of marijuana in the federal-based United States, most banks do not want to deal with cannabis-related businesses because they may be considered to commit a crime against the act. Consequently, this causes cannabis businesses to be almost entirely cash-based and poorly equipped to scale, pay taxes, and source funding.

By rescheduling marijuana as Schedule III:

  • Cannabis companies may have better access to mainstream banking services.
  • Although the reform proposals do not directly change banking access, the rescheduling may open the path for banks and credit unions to be able to provide safe financial services to cannabis businesses. 
  • This would substantially limit the danger of being in the cannabis industry and aid in normalizing the sector.

The cannabis market can also expand based on access to banking. With safe financial systems, cannabis companies can access institutional investors, take loans, and have long-term business plans. However, companies might also elaborate sturdier accounting procedures, making operating as a cash business less risky.

Economic Growth

The economic implications of cannabis reform cannot be stressed upon enough. Cannabis has already demonstrated that it is a force to reckon with in terms of the economy, having already generated billions of sales and provided thousands of employment opportunities in different sectors. The North American legal cannabis market is estimated to grow over 285 billion dollars in 2034.

Since Trump has announced changes to cannabis reform proposals, the industry may grow even more. 

  • A legal cannabis business would be more productive, and research and development could possibly result in the development of new products and services. 
  • Also, removing federal limitations may enable more states to legalize cannabis and foster market growth.

At the local level, cannabis reformation may result in elevated state and municipal tax revenue. A cannabis sales tax could yield a large revenue, which can be used to finance the healthcare, educational, infrastructural, and safety needs of the community in the states in which cannabis can be legally used. This may ease budgetary strains in deficit states and enhance societal services, resulting in a good cycle of economic growth.

Job Creation

Another important plus of cannabis reform is job creation. The industry is still in its initial stages of development, and as it spreads, it will need employees in various industries, including agriculture and retail. Both farming and the production, marketing, and sale of legalized cannabis require skilled labor forces, such as cultivation techs, quality control specialists, budtenders, compliance technicians, and marketing professionals.

In addition, the growth of medical cannabis research and manufacturing potential might lead to new jobs related to:

  • Researchers
  • Laboratory specialists
  • Healthcare professionals

These employment opportunities, in turn, may work to curb unemployment in areas that adopt cannabis legalization and, in fact, provide a steady economic base to communities.

Problems and Issues

Legislative Hurdles

Although the policy input by President Trump on weed has provided cannabis reform support, there are still prominent challenges to the legislation’s success. 

  • To reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act would require not only executive action but also the affirmation of federal agencies such as the DEA and the FDA. 
  • Additionally, Congress should approve a law on total cannabis reform, which should establish a practical regulatory framework for the industry. This, however, is not only hectic but also cumbersome and may be fraught with political problems. The legal process is tedious, especially when it involves a controversial subject as the legalization of cannabis. 

The progressive increase in the number of individuals who adhere to the view that legalization should take place is against political and social opposition. Most legislators have shown no interest in joining the cannabis reform effort because the practice is not a fad in the American conservative lands. 

Another dilemma can be observed in the fabric of the state policies on cannabis as well. It is hard to follow varying state rules, particularly for companies running businesses in two or more states. That brings about wastefulness, difficulty in following regulations, and high operational costs. These obstacles suggest that it is not easy to question the possibility of offering a united, nationwide cannabis policy that can obstruct the prospects of a strictly checked beneficial cannabis economy in the United States.

Industry Uncertainty

The regulatory environment in the cannabis industry is dynamic and unpredictable, and changes may occur very quickly. Although there is hope that President Trump will implement his cannabis reform proposals, companies must always be adaptable and open to unexpected obstacles. Cannabis laws at the federal level might still change, and new regulations and limitations may be implemented by state governments, which can affect everyday operations.

To illustrate, despite being rescheduled, the cannabis section may still be restricted by severe advertising, distribution, and packaging restrictions. These restrictions may affect the way businesses promote their products, access consumers, and abide by state/federal regulations. Due to changes in the regulatory environment, organizations should be prepared to adapt their business models.

Monitoring the changes in local and state laws and even federal laws regarding cannabis is crucial to be in line and not be punished. This might require companies to spend on the services of lawyers or lobby to make their business adhere to the changing regulations. Regulatory changes, especially concerning licensing and hemp, may be allowed at any time, so the ability to adjust rapidly and effectively will define how organizations will make it through the uncertainties of the cannabis industry and establish a business that lasts.

Conclusion

The cannabis reform plans of President Trump hold great potential for the cannabis market in 2025. The companies within the cannabis industry can gain much since the proposals (to be provided) can result in the rescheduling of marijuana, allow more research, better access to banking systems, and even more economic growth. Still, these reforms are not easy. Lawmaking is quite cumbersome and it is unclear how the legal environment is going. 

Nonetheless, with these reforms gaining momentum, cannabis enterprises need to be ready to face the new legal environment. Industry players, such as manufacturers, retailers, and customers (growers), must remain updated and flexible to help them manage the change. Gaining insights into how the cannabis reform under Trump would restructure policies, regulations, and the market will be critical for businesses that want to explore emerging opportunities but reduce trade-offs. The era of change brings both threats and development potential to the cannabis industry. Canna businesses can gain the edge only when they will proactively keep tabs on the proposed changes. 

Saira Zulfiqar

Written by:

Dr. Saira Zulfiqar, PharmD

Dr. Saira Zulfiqar is a pharmacist and cannabis expert with more than 15 years of experience. She graduated in 2008 with a Doctor of Pharmacy degree from the University of Punjab, the top-ranking and oldest university in Pakistan. Saira has consulted for and worked with numerous international cannabis, hemp, biomedical, and pharmaceutical companies.